Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral:
Three in vivo tests are available.
Key study:
The study to investigate acute oral toxicity of the test item, was conducted on female Sprague-Dawley (SD) rats in compliance with OECD 423 and GLP. The LD50 was determined to be > 2000 mg/kg body weight.
Supporting study:
The acute oral toxicity to Sprangue-Dawley rats were determined by the acute digestive tract route in accordance with GB/T 21603-2008 Chemicals-Test method of acute oral toxicity (similar to OECD 401). The acute oral LD50 of test item were 1710 mg/kg and 2330 mg/kg for female and male rats separately. No table for general findings and necropsy is shown and also no certificate for the test substance is included.
An acute oral toxicity test was conducted with fixed dosed method (similar to OECD 420). All 5 female animals were dosed at the same time. The LD50 was determined to be > 2000 mg/kg bw.
Inhalation: No study available
Dermal:
The acute dermal toxicity of the test substance to SD rats was determined in accordance with GB/T 21606-2008 Chemicals-Test method of acute dermal toxicity (similar to OECD 402). The acute dermal LD50 of the test substance for male and female rats was estimated to be over 2000 mg/kg.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- From 2014-10-15 to 2014-12-16
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- other: GB/T 21603-2008 Chemicals-Test method of acute oral toxicity
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- No table for general findings and necropsy is shown and also no certificate for the test substance is included
- GLP compliance:
- no
- Remarks:
- authorized by CNAS
- Limit test:
- no
- Specific details on test material used for the study:
- - Purity: 100.0%
- Lot No.: KNC110310 - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Slac Jingda Laboratory Animal Co., Ltd, Hunan Province.
- Weight at study initiation: 189 ~ 220 g
- Fasting period before study: Food but not water was withheld overnight to rats
- Housing: housed in SPF Barrier environment
- Diet: All of the feeds were supplied by Tianqin biotechnology Ltd., Changsha
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 ~ 22
- Humidity (%): 56-69 - Route of administration:
- oral: gavage
- Vehicle:
- methylcellulose
- Details on oral exposure:
- - Test solution preparation:
An amount of test item was grinded and then diluted into required concentration 46.4 mg/mL, 100 mg/mL, 215 mg/mL and 232 mg/mL for the test with 1% methylcellulose solution.
- Administration:
The dosing liquids were administered orally to rats by gavage for 1.0 mL/100 g BW (except 4640 mg/kg group for 2.0 mL/100 g BW). - Doses:
- 464 mg/kg, 1000 mg/kg, 2150 mg/kg and 4640 mg/kg
- No. of animals per sex per dose:
- 5 animals per sex per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Mortality and clinical/behavioral signs of toxicity were recorded daily thereafter for 14 days. Body weights were recorded at Day 0, 7, and 14.
- Necropsy of survivors performed: yes - Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 710 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 1 260 - < 2 330
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 330 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 1 600 - < 3 390
- Mortality:
- All of the animals in the high dose group died during the time of 2-24 h after administration. The animals in the second high dose group died during the time of 6 - 24 h and the survival animals recovered in the time of the fourth day after administration. No death occurred during the 14 days in the low and medium dose groups.
- Clinical signs:
- The animals in the second high dose group and high dose group were lack of movement in the time of 30 minutes after administration. Clothing hair fluffiness and bad of mental status were observed later. The animals in the medium dose group were lack of movement in the time of 6 hours and recovered in the time of 24 hours after administration. No detectable clinical signs occurred in any test animal of low dose group.
- Body weight:
- Individual body weights increased at the 7th and 14th day after dosing.
- Gross pathology:
- No abnormal necropsy findings occurred in any dead animal. No abnormal necropsy findings occurred in any animal of low and medium dose groups.
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- The acute oral LD50 of test item were 1710 mg/kg and 2330 mg/kg for female and male rats separately.
- Executive summary:
The acute oral median lethal dose and the health hazards of the test substance to Sprangue-Dawley rats were determined by the acute digestive tract route in accordance with GB/T 21603-2008 Chemicals-Test method of acute oral toxicity. Four dose groups (5 males and 5 females each group) were used. The dose levels were 464 mg/kg, 1000 mg/kg, 2150 mg/kg and 4640 mg/kg.
The animals in the second high dose group and high dose group were lack of movement in the time of 30 minutes after administration. Clothing hair fluffiness and bad of mental status were observed later. The animals in the medium dose group were lack of movement in the time of 6 hours and recovered in the time of 24 hours after administration. No detectable clinical signs occurred in any test animal of low dose group. No abnormal necropsy findings occurred in any dead animal. No abnormal necropsy findings occurred in any animal of low and medium dose groups. Individual body weights increased at the 7th and 14th day after dosing.
The acute oral LD50 of test item were 1710 mg/kg and 2330 mg/kg for female and male rats separately.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- 1 (reliable without restriction)
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- the study does not need to be conducted because exposure of humans via inhalation is not likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size
- Clinical signs:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2014-12-01 to 2014-12-16
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- other: GB/T 21606-2008 Chemicals-Test method of acute dermal toxicity
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Remarks:
- authorized by CNAS
- Limit test:
- yes
- Specific details on test material used for the study:
- - Purity: 100.0%
- Lot No.: KNC110310 - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Slac Jingda Laboratory Animal Co., Ltd, Hunan Province
- Weight at study initiation: 208 ~ 232 g
- Housing: housed in SPF Barrier environment
- Diet: AII ofthe feeds were supplied by Tianqin biotechnology Ltd, Changsha
- Acclimation period: at least 3 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-22
- Humidity (%): 56-69 - Type of coverage:
- occlusive
- Vehicle:
- methylcellulose
- Details on dermal exposure:
- About 4 cm x 5 cm areas of fur was clipped from the rats' back at 24 h before dosing. An amount of test item was grinded and then diluted into required concentration 500 mg/mL for the test with 1 % methylcellulose solution. The dosing Iiquids was equably applied to the smooth area (approximately 10 percent of the body surface area) of the rats in a single dose (0.4 mL/100 g BW) . The area of application was covered with a 2 ply in surgical gauze patch and secured in non-irritating adhesive tape.
- Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5 femles and 5 males
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Mortality and clinical/behavioral signs of toxicity were made daily thereafter for 14 days. Body weights were records at Day 0, 7 and 14.
- Necropsy of survivors performed: yes - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No death occurred during the 14 days
- Clinical signs:
- No detectable clinical signs occurred in any test animals during the 14 days.
- Body weight:
- Individual body weights increased at the 7th and 14th day after dosing.
- Gross pathology:
- No abnormal necropsy findings occurred in any test animal.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute dermal LD50 of the test substance for male and female rats was estimated to be over 2000 mg/kg.
- Executive summary:
The acute dermal median lethal dose and the health hazards of the test substance to SD rats were determined in accordance with GB/T 21606-2008 Chemicals-Test method of acute dermal toxicity. One single dose of 2000 mg/kg was chosen.
No detectable clinical signs occurred in any test animals, and no death occurred during the 14 days. Individual body weights increased at the 7th and 14th day after dosing. No abnormal necropsy findings occurred in any test animal.
The acute dermal LD50 of the test substance for male and female rats was estimated to be over 2000 mg/kg.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- 1 (reliable without restriction)
Additional information
Justification for classification or non-classification
Acute toxicity:
Oral:
Acute oral toxicity test, OECD 423, GLP, Korean lab: LD50: > 2000 mg/kg body weight for female.
Acute oral toxicity test, similar to OECD 401, China lab: LD50:1710 mg/kg for female and 2330 mg/kg for male rats.
Acute oral toxicity test, similar to OECD 420: LD50 > 2000 mg/kg bw for female
The China lab cannot be used as key study because it is reliable with restriction as no table for general findings and necropsy is shown and also no certificate for the test substance is included. And the study report of the Korean lab is used as a key report and used for classification by refer LD50 value (>2000 mg/kg for female) in the report.
Dermal:
Acute dermal test, similar to OECD 402: LD50 >2000 mg/kg.
Therefore in accordance with Regulation (EC) No. 1272/2008 (amended by 286/2011) Table 3.1.1, this substance should be not classified for acute oral and dermal toxicity.
Specific target organ toxicity-single exposure:
Oral:
Acute oral toxicity test, OECD 423:
Mortality: 1 animal (on day 1) at 2000 mg/kg B.W. died.
Clinical observations: no clinical signs caused by administration of the test substance.
Necropsy: Dead animal, hemorrhage in around mouth in external finding was observed. Surviving animals: no abnormal findings
Acute oral toxicity test, similar to OECD 401:
Mortality: All animal died in high dose group (10/10) and 4 females and 2 males died in the second high dose group
Clinical observations: The animals in the second high dose group and high dose group were lack of movement in the time of 30 minutes after administration. Clothing hair fluffiness and bad of mental status were observed later. The animals in the medium dose group were lack of movement in the time of 6 hours and recovered in the time of 24 hours after administration. No detectable clinical signs occurred in any test animal of low dose group.
Necropsy: No abnormal necropsy findings occurred in any dead animal. No abnormal necropsy findings occurred in any animal of low and medium dose groups.
Acute oral toxicity test, similar to OECD 420:
Mortality: No mortality occurred
Clinical observations: Irregular respiration was observed in 1/5 rats 30 min after dosing, and in 4/5 rats 1-4 h after administration. A decrease of spontaneous activity was also noted in 1/5 animals 30 min after dosing, increasing to 2-3/5 animals 1-4 h after administration. Muscular rigidity was noted in 2-5 rats, in an increasing number from 1 to 4 h after administration. Stains around the eyes and snout were observed in all 5 animals on Day 1, persisting until Day 2 in 1/5, while stains around the mouth was observed in 3/5 Day 1. Clonic convulsion were noted in 1/5 rats 4h after dosing. Urinary incontinence were noted in 1/5 rats during Day 1. No clinical signs were observed from Day 3 onward.
Necropsy: No substance-related findings were noted
Dermal:
Acute dermal test, similar to OECD 402:
Mortality: No death occurred
Clinical observations: No detectable clinical signs occurred in any test animals
Necropsy: No abnormal necropsy findings occurred in any test animal
In accordance with Regulation (EC) No. 1272/2008 section 3.8.2.1.7., the effects observed are not considered as adverse effects that support classification, therefore this substance should be not classified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.